ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 137 filers reported holding ITEOS THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 6.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $8,304,464 | +84778.0% | 559,600 | -22.0% | 0.01% | -6.7% |
| Q1 2024 | $9,784 | +27.8% | 717,300 | +2.6% | 0.02% | +25.0% |
| Q4 2023 | $7,653 | +77.4% | 698,900 | +77.4% | 0.01% | +71.4% |
| Q3 2023 | $4,314 | -21.1% | 394,000 | -4.6% | 0.01% | -12.5% |
| Q2 2023 | $5,471 | +21.8% | 413,200 | +25.3% | 0.01% | +33.3% |
| Q1 2023 | $4,490 | -27.5% | 329,900 | +4.0% | 0.01% | -25.0% |
| Q4 2022 | $6,193 | -99.9% | 317,100 | -19.3% | 0.01% | -27.3% |
| Q3 2022 | $7,485,000 | +9.3% | 392,900 | +18.2% | 0.01% | +37.5% |
| Q2 2022 | $6,845,000 | +58.5% | 332,300 | +147.6% | 0.01% | +60.0% |
| Q1 2022 | $4,319,000 | +180.3% | 134,200 | +305.4% | 0.01% | +150.0% |
| Q4 2021 | $1,541,000 | – | 33,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $36,261,513 | 17.78% |
| Saturn V Capital Management LP | 636,158 | $8,422,732 | 4.67% |
| MPM BioImpact LLC | 1,745,943 | $23,116,285 | 4.66% |
| Boxer Capital, LLC | 2,154,058 | $28,520 | 1.32% |
| RA Capital Management | 4,417,259 | $58,484,509 | 1.10% |
| Octagon Capital Advisors LP | 596,000 | $7,891,040 | 1.10% |
| BVF INC/IL | 1,810,835 | $23,975,455 | 0.67% |
| 683 Capital Management, LLC | 585,000 | $7,745,400 | 0.56% |
| AlphaCentric Advisors LLC | 63,000 | $834,120 | 0.46% |
| DAFNA Capital Management LLC | 98,560 | $1,304,934 | 0.36% |